Back
EACVI Premium Access

Left atrial myopathy and mitral regurgitation in hypertrophic cardiomyopathy

Session: e-posters session - Echocardiography
Topic: Myocardial Disease
Speaker: Doctor T. Zegkos (Thessaloniki, GR)
Event: EuroEcho 2021

Congress Presentation

0

About the speaker

Doctor Thomas Zegkos

Ahepa General Hospital of Aristotle University, Thessaloniki (Greece)
0 follower

290 more presentations in this session

Association of 24-hour ambulatory central aortic pressure and left atrium-ventriculo-arterial interactions

Speaker: Doctor N. Georgieva (Sofia, BG)

Access
Abstract
Slides
0
Thumbnail

Breast cancer patients presenting with cardiotoxicity - risk factors and role of cardioprotective drugs

Speaker: Doctor M. Martins de Carvalho (Porto, PT)

Access
Abstract
Slides
0
Thumbnail

Global longitudinal strain and territorial longitudinal strain in determining myocardial viability in out of window period anterior wall myocardial infarction patients

Access
Slides
0
Thumbnail

Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study

Speaker: Doctor F. Gonzalez Teston (Jerez de la Frontera, ES)

Access
Abstract
Slides
0
Thumbnail

Correlation between the left ventricular strain and the severity of coronary atherosclerosis in patients with coronary artery disease

Speaker: Doctor R. Alieva (Tashkent, UZ)

Access
Abstract
Slides
0
Thumbnail

Access the full session

e-posters session - Echocardiography

Speakers: Doctor T. Zegkos, Doctor N. Georgieva, Doctor M. Martins de Carvalho, Doctor F. Gonzalez Teston, Doctor R. Alieva
Access
0
Thumbnail

About the event

Image

EuroEcho 2021

9 December - 11 December 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?

29 August 2021

ESC Premium Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk